Le Lézard
Classified in: Mining industry, Business, Covid-19 virus
Subjects: EARNINGS, MISCELLANEOUS, MISCELLANEOUS

Unaudited interim results for the third quarter and nine month period ended 30 September 2021


For immediate release

30 November 2021

 

Serabi Gold plc

("Serabi" or the "Company")

Unaudited interim results for the third quarter and nine month period ended 30 September 2021

 

Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold mining and development company, today releases its unaudited results for the nine month period ended 30 September 2021 ("the Period")

 

A copy of the full interim statements together with commentary can be accessed on the Company's website using the following link ? https://bit.ly/3E8x0OkE8x0Ok

 

Financial Highlights

Operational Highlights

Clive Line, CFO of Serabi commented,

 

"Gold sales completed during the nine months to 30 September 2021 have totalled 25,434 ounces with total production for the period being 26,190 ounces with the third quarter representing another solid quarter of production with 9,035 ounces of gold.

 

"Operating costs have increased year on year by US$2.3 million, following the return of contractors to undertake underground drilling activities. US$1.0 million has been incurred in underground drilling year to date to improve short term and long term mine planning. Labour costs have also increased by US$0.76 million compared with 2020 reflecting the return to normal working routines compared with the lower staffing levels experienced during 2020 when at the peak of the pandemic it was necessary to reduce staff headcount at the mine sites.

 

"Whilst the AISC for the year to date of US$1,307 per ounce is slightly higher than that for the equivalent period in 2020, this is reflective of the increased level of mine development. The cash cost of production has reduced by 4% to US$976 per ounce.

 

"Cash holdings of US$15.2 million at the end of the period reflect operating cash flow of US$8.15 million from the Palito Complex operations, including mine development of US$3.8 million. Expenditure during the last 3 months on the Coringa operation has increased significantly following the start of the initial mine development including the establishment of the mine portal for the Serra deposit. The ramp has now achieved approximately 90 metres of development. Expenditure on the project in the nine months to the end of September was US$3.0 million with US$1.7 million incurred in the third quarter.

 

"Expenditure on purchases of new plant and equipment, exploration activities and the development of Coringa has totalled US$8.7 million for the year to date which has been met by the cash flow being generated by the current production operations.

 

"The financial results reflect the continuing benefits of solid gold production over the first nine months of 2021, a continued strong gold price and favourable exchange rates resulting in an EBITDA of US$15 million for the year to date.

 

"Gold prices, in USD terms, have fluctuated over the last two months in reaction to perceptions of world economies starting to improve and in particular signals of future interest rate increases in the United States and risk appetite. These fluctuations generally have been following movements in the US dollar against other world currencies and has been reflected in the relative movements of the Brazilian Real. The gold price in BRL terms remains strong."

Key Financial Information

 3 months to

30 September 2021

US$
3 months to

30 September 2020

US$
9 months to

30 September 2021

US$
9 months to

30 September 2020

US$
Revenue14,210,74915,941,96346,741,22245,403,793
Cost of sales(8,870,024)(8,487,475)(27,227,697)(24,908,688)
Gross operating profit5,340,7257,454,48819,513,52520,495,105
Administration and share based payments(1,391,574)(1,168,595)(4,514,034)(4,838,661)
EBITDA3,949,1516,285,89314,999,49115,656,444
Depreciation and amortisation charges(1,376,482)(1,484,715)(4,093,089)(4,716,809)
Operating profit / (loss) before finance and tax2,572,6694,801,17810,906,40210,939,635
     
Profit / (loss) after tax1,308,9483,779,9017,661,6017,419,295
Earnings per ordinary share (basic)1.73c6.41c10.64c12.58c
     
Average gold price received (US$/oz)US$1,753US$1,881US$1,772US$1,707
     
  As at

30 September 2021

US$
As at

31 December 2020

US$
As at

30 June 2020

(restated)

US$
Cash and cash equivalents 15,165,8756,603,62010,968,059
Net assets 79,937,36457,747,52452,923,589
     



Cash Cost and All-In Sustaining Cost ("AISC")    
  9 months to

30 September 2021
12 months to

31 December

2020
9 months to 30 September 2020
Gold production for cash cost and AISC purposes 26,190 ozs31,212 ozs24,748 ozs
     
Total Cash Cost of production (per ounce) US$976US$1,075US$1,013
Total AISC of production (per ounce) US$1,307US$1,374US$1,298


   SUMMARY PRODUCTION STATISTICS FOR 2021 AND 2020
  Qtr 1Qtr 2Qtr 3YTDQtr 1Qtr 2Qtr 3Qtr 4Full Yr
202120212021202120202020202020202020
           
Gold production (1)(2)Ounces8,0879,0489,03526,1909,0208,5046,7906,89831,212
Mined ore ? TotalTonnes40,37143,05142,240125,66342,03643,51944,09746,275175,928
 Gold grade (g/t)6.277.127.186.896.545.854.845.245.59
Milled oreTonnes41,46243,67941,995127,13740,46544,23546,13543,440174,276
 Gold grade (g/t)6.277.097.206.866.665.914.755.275.62
Horizontal development ? TotalMetres3,5732,9612,8429,3762,8783,0043,0373,35312,272
  1. The table may not sum due to rounding.
  2. Production numbers are subject to change pending final assay analysis from refineries.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. The person who arranged the release of this statement on behalf of the Company was Clive Line, Director.

 

Enquiries:

 

Serabi Gold plc 
Michael HodgsonTel: +44 (0)20 7246 6830
Chief ExecutiveMobile: +44 (0)7799 473621
  
Clive LineTel: +44 (0)20 7246 6830
Finance DirectorMobile: +44 (0)7710 151692
  
Email: contact@serabigold.com 
Website: www.serabigold.com 
  
Beaumont Cornish Limited

Nominated Adviser and Financial Adviser
 
Roland Cornish / Michael CornishTel: +44 (0)20 7628 3396
  
Peel Hunt LLP

Joint UK Broker
 
Ross Allister / Alexander AllenTel: +44 (0)20 7418 9000
  
Tamesis Partners LLP

Joint UK Broker
 
Charlie Bendon / Richard GreenfieldTel: +44 (0)20 3882 2868
  
Camarco        

Financial PR
 
Gordon Poole / Nick HennisTel: +44(0) 20 3757 4980

 

Copies of this announcement are available from the Company's website at www.serabigold.com.

 

Neither the Toronto Stock Exchange, nor any other securities regulatory authority, has approved or disapproved of the contents of this announcement.

 


The following information, comprising, the Income Statement, the Group Balance Sheet, Group Statement of Changes in Shareholders' Equity, and Group Cash Flow, is extracted from the unaudited interim financial statements for the six months to 30 June 2021

Statement of Comprehensive Income

For the nine month period ended 30 September 2021

  For the three months ended
30 September
For the nine months ended
30 September
  2021202020212020
(expressed in US$)Notes(unaudited)(unaudited and restated)(unaudited)(unaudited and restated)
CONTINUING OPERATIONS     
Revenue 14,210,74915,941,96346,741,22245,403,793
Cost of sales (8,870,024)(8,487,475)(27,227,697)(24,908,688)
Depreciation and amortisation charges (1,376,482)(1,484,715)(4,093,089)(4,716,809)
Total cost of sales (10,246,506)(9,972,190)(31,320,786)(29,625,497)
Gross profit  3,964,2435,969,77315,420,43615,778,296
Administration expenses (1,648,211)(1,042,013)(4,654,625)(4,705,158)
Share-based payments (71,903)(182,740)(208,103)(344,578)
Gain on disposal of assets 328,54056,158348,694211,075
Operating profit 2,572,6694,801,17810,906,40210,939,635
Foreign exchange gain/(loss) 125,56651,64281,823(99,032)
Finance expense218,140(376,498)(322,418)(1,308,463)
Finance income2?16,547?53,736
Profit before taxation 2,716,3754,492,86910,665,8079,585,874
Income tax expense3(1,407,427)(712,966)(3,004,206)(2,166,581)
Profit after taxation 1,308,9483,779,9017,661,6017,419,295
      
Other comprehensive income (net of tax)     
      
Exchange differences on translating foreign operations (4,468,408)(1,397,149)(2,240,458)(20,614,659)
Total comprehensive profit /(loss) for the period(1) (3,159,460)2,382,7525,421,143(13,195,364)
      
Profit per ordinary share (basic)41.73c6.41c10.64c12.58c
Profit per ordinary share (diluted)41.70c5.97c10.47c11.71c

(1)         The Group has no non-controlling interests and all losses are attributable to the equity holders of the parent company.

 

 

 

 

 


Balance Sheet as at 30 September 2021

(expressed in US$)Notes 

As at
30 September 2021 (unaudited)
As at
30 September 2020
(unaudited and restated)
As at
31 December 2020
(audited)
Non-current assets     
Deferred exploration costs6 33,034,34224,297,18227,778,354
Property, plant and equipment7 26,476,34223,198,93526,235,551
Right of use assets8 2,274,2812,207,2972,573,738
Taxes receivable  1,257,745828,083696,077
Deferred taxation  637,071229,4641,879,158
Total non-current assets  63,679,78150,760,96159,162,878
Current assets     
Inventories9 7,771,4275,308,0126,979,438
Trade and other receivables  2,147,5032,076,2631,936,044
Prepayments and accrued income  2,313,4842,329,7701,554,991
Cash and cash equivalents  15,165,87510,968,0596,603,620
Total current assets  27,398,28920,682,10417,074,093
Current liabilities     
Trade and other payables  7,155,7644,573,9886,846,202
Interest bearing liabilities10 278,85711,379,0698,726,302
Derivative financial liabilities11 ?411,123390,456
Accruals  396,670293,062292,089
Total current liabilities  7,831,29116,657,24216,255,049
Net current assets  19,566,9984,024,862819,044
Total assets less current liabilities  83,246,77954,785,82359,981,922
Non-current liabilities     
Trade and other payables  83,72282,26191,916
Interest bearing liabilities10 538,144181,348350,931
Deferred tax liability  903,421?324,519
Derivative financial liabilities11 394,529??
Provisions  1,389,5991,598,6251,467,032
Total non-current liabilities  3,309,4151,862,2342,234,398
Net assets  79,937,36452,923,58957,747,524
Equity     
Share capital14 11,213,6188,905,1168,905,116
Share premium reserve  36,158,06821,905,97621,905,976
Option reserve14 1,012,820984,3581,173,044
Other reserves  12,151,8739,970,27610,254,048
Translation reserve  (66,245,416)(69,028,477)(64,004,958)
Retained surplus  85,646,40180,186,34079,514,298
Equity shareholders' funds  79,937,36452,923,58957,747,524

The interim financial information has not been audited and does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. Whilst the financial information included in this announcement has been compiled in accordance with International Financial Reporting Standards ("IFRS") this announcement itself does not contain sufficient financial information to comply with IFRS. The Group statutory accounts for the year ended 31 December 2020 prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 have been filed with the Registrar of Companies. The auditor's report on these accounts was unqualified. The auditor's report did not contain a statement under Section 498 (2) or 498 (3) of the Companies Act 2006.


Statements of Changes in Shareholders' Equity

For the nine month period ended 30 September 2021

 

(expressed in US$)       
(unaudited)Share
capital
Share
premium
Share option reserveOther reserves (1)Translation reserveRetained EarningsTotal equity
Equity shareholders' funds at 31 December 2019 (restated)8,882,80321,752,4301,019,5897,149,274(48,413,818)75,208,23865,598,516
Foreign currency adjustments????(20,614,659)?(20,614,659)
Profit for the period?????7,419,2957,419,295
Total comprehensive income for the period????(20,614,659)7,419,295(13,195,364)
Shares issued in the period22,313153,456? ??175,859
Transfer to taxation reserve???2,821,002?(2,821,002)?
Share options exercised in period??(31,752)??31,752?
Share options lapsed in period??(348,057)??348,057?
Share option expense??344,578???344,578
Equity shareholders' funds at 30 September 2020 (restated)8,905,11621,905,976984,3589,970,276(69,028,477)80,186,34052,923,589
Foreign currency adjustments????5,023,519?5,023,519
Profit for the period?????(388,270)(388,270)
Total comprehensive income for the period????5,023,519(388,270)(388,270)
Transfer to taxation reserve???283,772?(283,772)?
Share option expense??188,686???188,686
Equity shareholders' funds at 31 Dec 20208,905,11621,905,9761,173,04410,254,048(64,004,958)79,514,29857,747,524
Foreign currency adjustments????(2,240,458)?(2,240,458)
Profit for the period?????7,661,6017,661,601
Total comprehensive income for the period????(2,240,458)7,661,6015,421,143
Transfer to taxation reserve???1,897,825?(1,897,825)?
Share Premium???????
Share Issued during period2,308,50214,252,092????16,560,594
Share options lapsed in period??(368,327)??368,327?
Share option expense??208,103???208,103
Equity shareholders' funds at 30 September 202111,213,61836,158,0681,012,82012,151,873(66,245,416)85,646,40179,937,364

(1) Other reserves comprise a merger reserve of US$361,461 and a taxation reserve of US$11,790,412 (31 December 2020: merger reserve of US$361,461 and a taxation reserve of US$9,892,587).

 


Cash Flow Statement

For the nine month period ended 30 September 2021

 For the three months
ended
30 September
For the nine months
ended
30 September
 2021202020212020
(expressed in US$)(unaudited)(unaudited)(unaudited)(unaudited)
Operating activities    
Post tax profit for period1,308,9483,779,9017,661,6017,419,295
Depreciation ? plant, equipment and mining properties1,376,4821,484,7154,093,0894,716,809
Net financial expense(143,706)308,309240,5951,353,759
Provision for taxation1,407,427712,9663,004,2062,166,581
Share-based payments71,903182,740208,103399,284
Taxation Paid(203,221)?(333,922)?
Interest Paid(12,891)(2,753)(1,295,724)(265,751)
Foreign exchange (loss) / gain49,636(79,732)(138,928)(125,537)
Changes in working capital    
 (Increase)/decrease in inventories(663,820)55,650(763,112)(733,883)
 (Increase) in receivables, prepayments and accrued income(259,673)(997,396)(1,104,846)(1,997,572)
 Increase/(decrease) in payables, accruals and provisions287,149277,539378,041220,307
Net cash inflow from operations3,218,2345,721,94211,949,10313,153,292
     
Investing activities    
Purchase of property, plant and equipment and assets in construction(1,698,160)(860,020)(2,439,463)(2,049,973)
Mine development expenditure(1,244,454)(784,203)(3,802,795)(2,005,880)
Geological exploration expenditure(1,474,640)(267,338)(3,274,609)(1,352,610)
Pre-operational project costs(1,753,513)(149,457)(3,019,404)(627,097)
Acquisition payment for subsidiary?(2,500,000)(5,500,000)(3,500,000)
Acquisition of other property rights(930)(150,789)(102,316)(483,302)
Proceeds from sale of assets340,66472,188365,745400,047
Interest received???911
Net cash outflow on investing activities(5,831,033)(4,639,619)(17,772,842)(9,617,904)
     
Financing activities    
Issue of Ordinary share capital (net of costs)??16,560,594?
Issue of warrants??333,936?
Drawdown of convertible loan?500,000?2,000,000
Repayment of convertible loan??(2,000,000)?
Repayment of secured loan???(6,983,492)
Payment of finance lease liabilities(85,990)(203,080)(349,269)(249,354)
Net cash (outflow) / inflow from financing activities(85,990)296,92014,545,261(5,232,846)
     
Net increase / (decrease) in cash and cash equivalents(2,698,789)1,379,2428,721,522(1,697,458)
Cash and cash equivalents at beginning of period18,121,3929,627,4126,603,62014,234,612
Exchange difference on cash(256,728)(38,596)(159,267)(1,569,095)
Cash and cash equivalents at end of period15,165,87510,968,05915,165,87510,968,059



Notes

1. Basis of preparation
These interim condensed consolidated financial statements are for the nine month period ended 30 September 2021. Comparative information has been provided for the unaudited nine month period ended 30 September 2020 and, where applicable, the audited twelve month period from 1 January 2020 to 31 December 2020. These condensed consolidated financial statements do not include all the disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 2020 annual report.
The condensed consolidated financial statements for the periods have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" and the accounting policies are consistent with those of the annual financial statements for the year ended 31 December 2020 and those envisaged for the financial statements for the year ending 31 December 2021.

Accounting standards, amendments and interpretations effective in 2021

The Group has not adopted any standards or interpretations in advance of the required implementation dates.

The following Accounting standards came into effect as of 1 January 2021

 Effective Date
Amendments to IFRS 9, IAS 39,IFRS 7, IFRS 4 and IFRS 16 Interest Rate benchmark Reform ? Phase 21 January 2021

 

The adoption of this standard has had no effect on the financial results of the Group.

 

There are a number of standards, amendments to standards, and interpretations which have been issued that are effective in future periods and which the Group has chosen not to adopt early. None of these are expected to have a significant effect on the Group, in particular

 Effective Date
Property, Plant and Equipment ? Proceeds before Intended Use (amendments to IAS 16)1 January 2022
Onerous Contracts- Cost of Fulfilling a Contract (Amendments to IAS 37)1 January 2022
Annual Improvements to IFRS Standards 2018-20201 January 2022
Reference to Conceptual Framework (Amendments to IFRS 3)1 January 2022
IFRS 17 Insurance Contracts, including Amendments to IFRS 171 January 2023
Classification of Liabilities as Current or Non-current (Amendments to IAS 1) and Classification of Liabilities as Current or Non-current ? Deferral of Effective Date1 January 2023

These financial statements do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006.

(i) Going concern

On 2 March 2021, the Group announced that it had concluded a placing of new shares raising gross proceeds of £12.5 million. The shares were issued and admitted to trading on AIM and listed on the TSX on 9 March 2021.

Following completion of the placing, the Group settled the remaining deferred consideration due to Equinox for the acquisition of Coringa amounting to US$2.5 million plus accrued interest of US$1.09 million. The Group also redeemed US$2.0 million of convertible loan stock held by Greenstone together with interest and other agreed fees totalling US$533,560. Following the settlement of these liabilities, the Group has no long-term borrowings or debt, and all security interests held by Equinox and Greenstone have been released.

The Group is using some of the proceeds from the balance of the funds raised through the placing of new shares to start the development of the mine at Coringa during 2021 and also to fund the Group's exploration programme for 2021.

The Group expects that it will use a combination of debt finance and cash flow from its existing operations to meet the further development costs of Coringa until that project reaches a position of sustained positive cash-flow. The preliminary economic assessment issued by the Group in October 2019, estimated an initial capital requirement of US$24.7 million prior to sustained positive cash-flow. Management estimates that first gold production could occur 18 to 24 months after the commencement of initial mine development.

As with most businesses, the long term potential impacts of COVID-19 create uncertainty but management considers the actions and procedures that have been implemented by the Group and its history over the past 15 months of dealing with the effects of the pandemic, are minimising the potential for any significant and extended effect on the business and its operations. Management and the Board will continue to assess any further actions that may be necessary, but at this time, based on the information currently available and experiences to date, consider that the measures currently in place will permit the Group to maintain operations at forecast rates of production.

The Group did not claim or receive any COVID-19 related grants or other funding from any government or other sources, during 2020 or 2021 and has no expectation of receiving any such financial support in the future.

The Directors are confident as at the date of this report of being able to raise the necessary debt funding for the continued development of Coringa, as and when necessary. Whilst the Group's operations are performing at the levels that they anticipate, the Directors acknowledge that unplanned interruptions or other events resulting in a reduction in gold production and/or any significant reduction of the gold price or appreciation of the Brazilian Real could adversely affect the level of free cash flow that the Group can generate on a monthly basis. The Group maintains stocks of spare parts, and the modular nature of the plant should permit gold production to continue in the event of breakdowns. The Group constantly monitors gold price and exchange rate and will use hedging facilities to protect its cash flow where appropriate. .Should it be required the Board could also reduce the planned level of exploration expenditure or reduce the planned rate of expenditure on the development of Coringa to reduce cash outflows.

On this basis, the Directors have therefore concluded that it is appropriate to prepare the financial statements on a going concern basis..

2.        Finance expense and income

 3 months ended

30 September 2021

(unaudited)
3 months

ended

30 September 2020

(unaudited)
9 months ended

30 September 2021

(unaudited)
9 months

ended

30 September 2020

(unaudited)
   US$US$
Interest expense on secured loan???(203,127)
Interest expense on convertible loan?(64,292)(47,502)

(81,816)
Interest expense on mineral property acquisition liability?(255,956)(23,854)(849,970)
Recognition of variation in effective interest rate of secured loan???(79,800)
Loss in respect of non-substantial modification?(155,237)(40,469)?
Warrants Expense18,140?(60,593)?
Amortisation of arrangement fee for convertible loan?(56,250)(150,000)(93,750)
Loss on revaluation of derivatives????
Total finance expense18,140(376,498)(322,418)(1,308,463)
Gain in respect of non-substantial modification???40,469
Gain on revaluation of derivatives?16,547?12,356
Interest income???911
Total finance income?16,547?53,736
Net finance income/(expense)18,140(359,951)(322,418)(1,254,727)

3.         Taxation

The Group has recognised a deferred tax asset to the extent that the Group has reasonable certainty as to the level and timing of future profits that might be generated and against which the asset may be recovered. The Group has released the amount of US$1,149,614 as a deferred tax charge during the nine month period to 30 September 2021 (nine months to 30 September 2020 - US$794,044).

The Group has also incurred a tax charge on profits in Brazil for the nine month period of US$1,854,592 (nine months to 30 September 2020 - US$1,372,537).


4.        Earnings per Share

        3 months ended 30 September 2021
(unaudited)
3 months ended 30 September 2020
(unaudited)
9 months ended 30 September 2021
(unaudited)
9 months ended 30 September 2020
(unaudited)
Profit attributable to ordinary shareholders (US$)1,308,9483,779,9017,661,6017,419,295
Weighted average ordinary shares in issue75,734,55158,981,29072,014,22158,946,229
Basic profit per share (US cents)1.73c6.41c10.64c12.58c
Diluted ordinary shares in issue (1)76,901,22163,362,69473,180,89163,327,628
Diluted profit per share (US cents)1.705.97c10.47c11.71c

1) Based on 1,166,670 options vested and exercisable as at 30 September 2021 (30 September 2020: 2,435,088 options and 2,036,316 shares that could be issued pursuant to any exercise of conversion rights attaching to the Convertible Loan Notes.

5.        Post balance sheet events

Subsequent to the end of the period, there has been no item, transaction or event of a material or unusual nature likely, in the opinion of the Directors of the Company to affect significantly the continuing operation of the entity, the results of these operations, or the state of affairs of the entity in future financial periods.

 

Qualified Persons Statement

The scientific and technical information contained within this announcement has been reviewed and approved by Michael Hodgson, a Director of the Company. Mr Hodgson is an Economic Geologist by training with over 26 years' experience in the mining industry. He holds a BSc (Hons) Geology, University of London, a MSc Mining Geology, University of Leicester and is a Fellow of the Institute of Materials, Minerals and Mining and a Chartered Engineer of the Engineering Council of UK, recognising him as both a Qualified Person for the purposes of Canadian National Instrument 43-101 and by the AIM Guidance Note on Mining and Oil & Gas Companies dated June 2009.

 

Assay Results

The assay results reported within this release include those provided by the Company's own on-site laboratory facilities at Palito which may not have been independently verified.  Serabi closely monitors the performance of its own facility against results from independent laboratory analysis for quality control purpose.  As a matter of normal practice the Company sends duplicate samples derived from a variety of the Company's activities to accredited laboratory facilities for independent verification. Based on the results of this work, the Company's management are satisfied that the Company's own facility shows good correlation with independent laboratory facilities. The Company would expect that in the preparation of any future independent Reserve/Resource statement undertaken in compliance with a recognised standard, the independent authors of such a statement would not use Palito assay results but only use assay results reported by an appropriately certificated laboratory.

 

Forward Looking Statements

Certain statements in this announcement are, or may be deemed to be, forward looking statements. Forward looking statements are identi?ed by their use of terms and phrases such as ??believe'', ??could'', "should" ??envisage'', ??estimate'', ??intend'', ??may'', ??plan'', ??will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re?ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements.

 

ENDS



These press releases may also interest you

at 06:55
Ra Medical Systems, Inc. announces that Chief Executive Officer Will McGuire has issued the following Letter to Stockholders: To My Fellow Stockholders: I'm very proud of the Ra Medical team's significant progress in implementing engineering...

at 06:55
IFF today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board of Directors, effective February 14, 2022. Mr. Clyburn joins...

at 06:55
Merck , known as MSD outside the United States and Canada, and Eisai today announced the publication of results from the Phase 3 KEYNOTE-775/Study 309 trial in the January 19, 2022 edition of the New England Journal of Medicine. The pivotal study...

at 06:55
NovaBay® Pharmaceuticals, Inc. , a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces its commitment to donate 2.5 million KN95 protective...

at 06:55
The "Global Cash Logistics Market (2021 Edition) - Analysis By Service Type (RCM, DCV, ATM Cash Management), End User, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)" report has been added to...

at 06:50
The "Paper Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global paper packaging market exhibited moderate growth during 2015-2020....



News published on 30 november 2021 at 02:00 and distributed by: